Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/elpWCduTtWCibVpKCidncVCicNcveE
| Today's Top Story |  |  | | | Health Care & Policy | | | | - FDA OKs Bayer's Stivarga for gastrointestinal stromal tumor
The FDA approved Bayer HealthCare's Stivarga, or regorafenib, to treat patients with metastatic, locally advanced or unresectable gastrointestinal stromal tumors. The drug, which previously had been cleared for metastatic colorectal cancer, will be marketed in the U.S. with Onyx Pharmaceuticals. RTT News (2/25), Reuters (2/25)       - FDA seeks more data on Dynavax hepatitis B vaccine Heplisav
The FDA declined to approve Heplisav, an hepatitis B vaccine developed by Dynavax Technologies, and asked for more information on safety. In a complete response letter, the agency said it is open to a more limited use. Dynavax plans to meet with the FDA within six weeks. Reuters (2/25) - CEO says improving existing drugs can be a revenue driver
Despite criticism about creating retreads, pharmaceutical companies pass up a valuable opportunity when they fail to improve upon existing drugs, says SciFluor Life Sciences CEO Arthur Hiller. The startup used that philosophy when it licensed Harvard-developed methods for inserting fluorine into an existing drug to reshape its chemistry. The company is patenting the new compounds and looking for partners. Xconomy (2/25) | Company & Financial News | | | | - Quest to divest HemoCue diagnostic biz for about $300 million
Radiometer Medical has agreed to acquire Quest Diagnostics' HemoCue business for about $300 million, plus cash balance adjustments, in a deal set to be finalized next month. HemoCue focuses on developing and marketing point-of-care diagnostics, including those used in glucose and hemoglobin testing. RTT News (2/25) | Global Developments | | | | | Food & Agriculture | | | | | Industrial & Environmental | | | | - EPA OKs new biofuel pathways for camelina, others under RFS
The Environmental Protection Agency issued a final rule identifying pathways for biofuels derived from camelina, energy cane and renewable gasoline to qualify as feedstocks and fuels under the Renewable Fuel Standard. Under the pathways, camelina oil could qualify as biomass-based diesel or advanced biofuel, while energy-cane-based biofuel and renewable gasoline derived from certain sources could qualify as cellulosic biofuel. DomesticFuel.com (2/25) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | Shared joys make a friend, not shared sufferings."
--Friedrich Nietzsche,
German philosopher  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, February 25, 2013
- Friday, February 22, 2013
- Thursday, February 21, 2013
- Wednesday, February 20, 2013
- Tuesday, February 19, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment